Related Experiment Video

Updated: Aug 14, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

Primary progressive multifocal leukoencephalopathy: report of a case

Valeria Isella1, Laura Marzorati, Natale Curtò

  • 1Neurology Section, S.Gerardo Hospital, Monza, University of Milan-Bicocca, Italy.

Functional Neurology
|December 6, 2005
PubMed

Insights

This case study details primary progressive multifocal leukoencephalopathy (pPML) in a patient with a competent immune system. Extensive investigations confirmed no underlying disorders, offering new insights into JC virus pathogenesis.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • Primary progressive multifocal leukoencephalopathy (pPML) is a rare demyelinating disease of the central nervous system.
  • PML is typically associated with severe immunosuppression, often due to conditions like HIV/AIDS or organ transplantation.
  • The JC virus (JCV) is the causative agent of PML, infecting oligodendrocytes and leading to progressive neurological damage.

Observation:

  • The presented case involves a patient diagnosed with pPML despite having a demonstrably competent immune system.
  • Extensive in vivo and post-mortem investigations were conducted to rule out any predisposing conditions or immune deficiencies.
  • These investigations confirmed the patient's immune competence and the absence of typical risk factors for PML.

Findings:

  • The case challenges the established paradigm that PML exclusively occurs in immunocompromised individuals.
  • The findings suggest that JCV may have alternative pathogenic mechanisms or that immune competence does not entirely preclude PML development.
  • Detailed pathological and immunological data provide a unique resource for understanding JCV infection dynamics.

Implications:

  • This case has significant clinical implications for the diagnosis and management of PML, potentially broadening the differential diagnosis.
  • It prompts a re-evaluation of the role of the immune system in controlling JCV infection and preventing PML.
  • Further research into the pathogenetic mechanisms of JCV in immunocompetent hosts is warranted to understand disease initiation and progression.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...